help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, H.
Right arrow Articles by Jetten, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, H.
Right arrow Articles by Jetten, A. M.

Am. J. Respir. Cell Mol. Biol., Volume 18, Number 3, March, 1998 323-333

Inhibition of Cell Proliferation and Induction of Apoptosis by the Retinoid AHPN in Human Lung Carcinoma Cells

Hiroshi Adachi, Gloria Preston, Beth Harvat, Marcia I. Dawson, and Anton M. Jetten

Laboratories of Pulmonary Pathobiology and Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; and Retinoid Program, SRI International, Menlo Park, California

In this study, we investigated the effect of the novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN/CD437) on the growth of human lung carcinoma cell lines. AHPN inhibits the proliferation of all cell lines tested, irrespective of the lung tumor type, in a concentration- and time-dependent manner. A dramatic reduction in cell number was observed in adenocarcinoma H460 cells, and was shown to be related to an induction of apoptosis. Bromodeoxyuridine (BrdU) incorporation and flow-cytometric analyses indicated that treatment of H460 cells with AHPN induces cell-cycle arrest at the G1 phase. We therefore investigated the effect of AHPN on several regulatory proteins of the G1 phase of the cell-cycle. The cell-cycle arrest induced by AHPN was accompanied by an inhibition of the hyperphosphorylation of the retinoblastoma (Rb) protein, an indication of G1 arrest. Furthermore, two cyclin-dependent kinases, cdk2 and cdk4, which are normally involved in the phosphorylation of Rb, were shown to have decreased activity. In some cell lines, the decrease in cdk activity may be partly related to an increase in p21WAF1/Cip1 (p21), an inhibitor of cyclin-dependent kinases. No changes were observed in the cyclin-dependent kinase inhibitor p27Kip1. The observed increase in p53 in response to AHPN could at least to some extent be responsible for the increased levels of p21. The increase in p53 expression was found to be regulated at a post-transcriptional level. Our results suggest that the growth inhibition of certain lung carcinoma cell lines by AHPN is at least partly related to an increase in p21. However, in other cell lines, different mechanisms appear to be involved. The specificity with which AHPN and other retinoids induce growth arrest and p21 expression indicates that the action of AHPN is not mediated by RAR or RXR receptors, but involves a novel signaling pathway.




This article has been cited by other articles:


Home page
 BloodHome page
Y. Zhang, M. I. Dawson, Y. Ning, L. Polin, R. E. Parchment, T. Corbett, A. N. Mohamed, K.-C. Feng, L. Farhana, A. K. Rishi, et al.
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog
Blood, November 15, 2003; 102(10): 3743 - 3752.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Newman, M. Sakaue, J. S. Koo, K.-S. Kim, S. J. Baek, T. Eling, and A. M. Jetten
Differential Regulation of Nonsteroidal Anti-Inflammatory Drug-Activated Gene in Normal Human Tracheobronchial Epithelial and Lung Carcinoma Cells by Retinoids
Mol. Pharmacol., March 1, 2003; 63(3): 557 - 564.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. R. Soprano and K. J. Soprano
Pharmacological Doses of Some Synthetic Retinoids Can Modulate Both the Aryl Hydrocarbon Receptor and Retinoid Receptor Pathways
J. Nutr., January 1, 2003; 133(1): 277S - 281.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Zhang, M. I. Dawson, R. Mohammad, A. K. Rishi, L. Farhana, K.-C. Feng, M. Leid, V. Peterson, X.-k. Zhang, M. Edelstein, et al.
Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog
Blood, September 26, 2002; 100(8): 2917 - 2925.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Besnard, J. Bakouche, Y. Lemaigre-Dubreuil, J. Mariani, A. Tedgui, and D. Henrion
Smooth Muscle Dysfunction in Resistance Arteries of the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha}
Circ. Res., April 19, 2002; 90(7): 820 - 825.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-Y. Sun, P. Yue, W. K. Hong, and R. Lotan
Augmentation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by the Synthetic Retinoid 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) through Up-Regulation of TRAIL Receptors in Human Lung Cancer Cells
Cancer Res., December 1, 2000; 60(24): 7149 - 7155.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. M. Schneider, M. Offterdinger, H. Huber, and T. W. Grunt
Activation of Retinoic Acid Receptor {{alpha}} Is Sufficient for Full Induction of Retinoid Responses in SK-BR-3 and T47D Human Breast Cancer Cells
Cancer Res., October 1, 2000; 60(19): 5479 - 5487.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
S. Y. Kim, H. Adachi, J. S. Koo, and A. M. Jetten
Induction of the Cytochrome P450 Gene CYP26 during Mucous Cell Differentiation of Normal Human Tracheobronchial Epithelial Cells
Mol. Pharmacol., September 1, 2000; 58(3): 483 - 490.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
S.-Y. Sun, P. Yue, R. A. S. Chandraratna, Y. Tesfaigzi, W. K. Hong, and R. Lotan
Dual Mechanisms of Action of the Retinoid CD437: Nuclear Retinoic Acid Receptor-Mediated Suppression of Squamous Differentiation and Receptor-Independent Induction of Apoptosis in UMSCC22B Human Head and Neck Squamous Cell Carcinoma Cells
Mol. Pharmacol., September 1, 2000; 58(3): 508 - 514.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S.-Y. Sun, P. Yue, L. Mao, M. I. Dawson, B. Shroot, W. W. Lamph, R. A. Heyman, R. A. S. Chandraratna, K. Shudo, W. K. Hong, et al.
Identification of Receptor-selective Retinoids That Are Potent Inhibitors of the Growth of Human Head and Neck Squamous Cell Carcinoma Cells
Clin. Cancer Res., April 1, 2000; 6(4): 1563 - 1573.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nabeyrat, S. Corroyer, R. Epaud, V. Besnard, V. Cazals, and A. Clement
Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21CIP1 downregulation
Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L42 - L50.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Marchetti, N. Zamzami, B. Joseph, S. Schraen-Maschke, C. Mereau-Richard, P. Costantini, D. Metivier, S. A. Susin, G. Kroemer, and P. Formstecher
The Novel Retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene Carboxylic Acid Can Trigger Apoptosis through a Mitochondrial Pathway Independent of the Nucleus
Cancer Res., December 1, 1999; 59(24): 6257 - 6266.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Sakaue, H. Adachi, and A. M. Jetten
Post-Transcriptional Regulation of MyD118 and GADD45 in Human Lung Carcinoma Cells During 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid-Induced Apoptosis
Mol. Pharmacol., April 1, 1999; 55(4): 668 - 676.
[Abstract] [Full Text]

Home page
 BloodHome page
L. Mologni, I. Ponzanelli, F. Bresciani, G. Sardiello, D. Bergamaschi, M. Gianni, U. Reichert, A. Rambaldi, M. Terao, and E. Garattini
The Novel Synthetic Retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases
Blood, February 1, 1999; 93(3): 1045 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Besnard, J. Bakouche, Y. Lemaigre-Dubreuil, J. Mariani, A. Tedgui, and D. Henrion
Smooth Muscle Dysfunction in Resistance Arteries of the Staggerer Mouse, a Mutant of the Nuclear Receptor ROR{alpha}
Circ. Res., April 19, 2002; 90(7): 820 - 825.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1998 American Thoracic Society.